Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the Fourth Quarter and Year ended March 31, 2026. 2. To consider and approve the amalgamation of M/s. Shri Shri Resorts Private Limited (Transferor Company) with and into M/s. Vivo Bio Tech Limited (Transferee Company) under Sections 230 to 232 and other relevant provisions of the Companies Act, 2013, SEBI Listing Regulations etc.